Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Wangari-Talbot

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Drugs in Dermatology : JDD|June 19, 2020
Long-Term Benefits of Daily Photo-Protection With a Broad-Spectrum Sunscreen in United States Hispanic Female PopulationPearl Grimes, Rebat Halder, Michele Verschoore, et al.
Pigment Cell & Melanoma Research|December 17, 2013
Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cellsBrian A Wall, Janet Wangari-Talbot, Seung S Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2011
Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapiesHwa Jin Lee, Brian A Wall, Janet Wangari-Talbot, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Drugs in Dermatology : JDD|June 19, 2020
Long-Term Benefits of Daily Photo-Protection With a Broad-Spectrum Sunscreen in United States Hispanic Female PopulationPearl Grimes, Rebat Halder, Michele Verschoore, et al.
Pigment Cell & Melanoma Research|December 17, 2013
Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cellsBrian A Wall, Janet Wangari-Talbot, Seung S Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2011
Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapiesHwa Jin Lee, Brian A Wall, Janet Wangari-Talbot, et al.
Pageof 2